Search Results 1201-1210 of 17627 for treatment resistant depression

1. Clinical trials - Oncology (Medical)

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

2. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea - Mayo Clinic

   By condition, treatment or drug name. Search tips ... Resistant to Hydroxyurea. Print details. Share ... treatment has been approved and is on the market.

3. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

   The purpose of this study is to evaluate HPN217 as monotherapy to assess the safety, tolerability and pharmacokinetics in patients with relapsed/ refractory ...

4. Using Technology to Optimize Child Mental Health Care In Real World Settings - Mayo Clinic

   By condition, treatment or drug name ... treatment tools to treat those with a mental health illness. ... depression, disruptive behavior); English speaking ...

5. A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic ...

6. CAR-T Cell Therapy Program - Clinical trials

   Rochester, Minn. The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and ...

7. Publications - Loren P. Murray, M.D. - Mayo Clinic

   Treatment Approach of Refractory ... Telephone-based, cognitive-behavioral therapy for African American dementia caregivers with depression: initial findings.

8. Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) - Mayo Clinic

   By condition, treatment or drug name. Search tips ... Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant ...

9. Psychiatry and Psychology - Doctors - Mayo Clinic

   Transcranial magnetic stimulation, Teen depression, Mood disorder, Childhood-onset disorder. Request an appointment · Conditions treatedSpecialty groups. July ...

10. A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions - Mayo Clinic

    Participant has any other medical condition, such as anxiety, depression, heart disease, or significant hepatic, pulmonary, or renal disease, that requires them ...